
Developed in collaboration with the Michael J Fox Foundation, this model contains a deletion of the Park2 gene, Parkinson disease (autosomal recessive, juvenile) 2, encoding for the protein Parkin.
In humans, loss of function of Park2 leads to a form of familial Parkinson's disease. The Parkin protein is part of the ubiquitin-proteasomal enzyme pathway and may help degrade other proteins that are toxic to neurons. Roughly 20% of patients with Parkinson's disease onset before age 40 have mutations within Park2, making this an ideal model for the study of Parkinson's disease.